Skip to content

Ketoacidosis in Individuals With Type I Diabetes Mellitus (T1DM)

Ketoacidosis in Individuals With T1DM

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00970567
Enrollment
19
Registered
2009-09-02
Start date
2007-11-30
Completion date
2008-12-31
Last updated
2009-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 Diabetes

Keywords

therapy after positive ketone bodies in the blood, timepoint of diagnosis, timepoint of metabolic normalisation

Brief summary

The purpose of this study is to investigate individuals with type 1 diabetes who were disconnected from their insulin pump and insulin therapy was started again after positive ketones (U) in the urine or blood β-hydroxybutyrate.

Detailed description

Individuals with type 1 diabetes were disconnected from their insulin pump and insulin therapy was started again after positive ketones (U) in the urine or blood β-hydroxybutyrate with different therapy regimens after positive blood ketones.

Interventions

BEHAVIORALDifferent insulin therapy at different time points

different insulin therapy after positive blood ketones

Sponsors

Abbott
CollaboratorINDUSTRY
Charite University, Berlin, Germany
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* type 1 diabetes

Exclusion criteria

* severe hypo- or hyperglycemia during last 6 months * acute illness

Design outcomes

Primary

MeasureTime frame
glucose metabolism, time course of positive ketone bodies6 hours

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026